Scientists and public health experts built the COVID-19 pandemic response on years of experience navigating infectious disease outbreaks. Although lateral flow immunoassays have been central to ...

Primary school pupils across England stepped back into the classroom this week after months away from education. The Government reintroduced the strictest Covid measures one day after they went back ...

In a recent review published in Nature Reviews Bioengineering, researchers assessed the changing landscape of lateral flow tests (LFTs), and the development of next-generation LFTs based on lessons ...

In this interview, News-Medical talks to Hasret Altan-Martin from Sartorius about the ongoing emergence of lateral flow assays in diagnostics. Before the COVID-19 pandemic, the pregnancy test was the ...

An artificial intelligence app to read COVID-19 lateral flow tests helped to reduce false results in a recent trial. An artificial intelligence app to read COVID-19 lateral flow tests helped to reduce ...

Lateral flow assays, also called immunochromatographic assays, identify or measure biomolecules in intricate samples like blood, saliva, urine, or other fluids to diagnose numerous medical conditions.

Lateral flow immunoassays (LFIAs) represent a class of paper-based diagnostic devices designed for rapid, on-site detection of specific biomarkers in complex samples. At their core, these assays rely ...

An artificial intelligence app to read COVID-19 lateral flow tests helped to reduce false results in a new trial out today. In work published in Cell Reports Medicine, a team of researchers from the ...